Glycosylation of ascites-derived exosomal CD133: a potential prognostic biomarker in patients with advanced pancreatic cancer

Takahiko Sakaue(Kurume University), Takuji Torimura(Omuta hospital)

Medical Molecular Morphology

February 25, 2019

10.1007/s00795-019-00218-5

Cited by 62

Related Papers

Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial

|Gut|2019|720

Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2021 version (5th JSH‐HCC Guidelines)

|Hepatology Research|2023|267

Effects of canagliflozin on growth and metabolic reprograming in hepatocellular carcinoma cells: Multi-omics analysis of metabolomics and absolute quantification proteomics (iMPAQT)

|PLoS ONE|2020|84

Acute presentation of autoimmune hepatitis: a multicentre study with detailed histological evaluation in a large cohort of patients

|Journal of Clinical Pathology|2017|81

Autoimmune hepatitis in Japan: trends in a nationwide survey

|Journal of Gastroenterology|2016|67